Anavex Life Sciences Corp (AVXL)

[Gator328]

I'm sorry to hear about your father. Alzheimer's is an awful disease (and I know many who are suffering from early stages of memory loss).

You have the right attitude -- if you believe that A273 is the next big thing in AD treatment, buy and buy some more because whether your avg. price is $10 or .10, you're still going to make a really nice return on the investment.

If you're trading this stock, AVXL is going to cause a lot of pain in the short term because the only real catalyst for a significant pop in the share price is trial data and/or partnership. We KNOW that the data is at least a year or two away -- they haven't even finished enrolling the trials yet. And while anything can happen with a surprise partnership announcement, the fact that AVXL has enough runway to get through the next 15 months or longer means that a partnership isn't urgent either. Missling is either very confident in the final outcome, or he's a gambler -- maybe a bit of both?

I don't like the short term outlook for Anavex stock because I see a company with no revenue and lots of expenses, and no immediately way to generate profits. And no sure thing that the primary asset even has any value. There isn't any cabal -- just lots of impatient retail holders who bought high and have reached the point where they're willing to sell low.

I love the long term outlook because if the drug turns out to be legit, it's an absolute game changer.

Unfortunately, we're at least a year or more away from finding out if this is the case. Another year or three isn't a long time for the patient investor. It's an eternity for the impatient investor and/or trader.